In prostate cancer cell line vitamin D led to upregulation of insulin-like growth factor binding protein-3 (IGFBP3), which can inhibit cell cycle through upregulation of p21 expression [67,68]. This evidence concerns the gene IGFBP3 and prostate cancer.